These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18992395)

  • 1. Global health-care implications of substandard medicines.
    Senior K
    Lancet Infect Dis; 2008 Nov; 8(11):666. PubMed ID: 18992395
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087
    [No Abstract]   [Full Text] [Related]  

  • 3. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 5. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 6. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 8. Inspections: the international regulatory view--Japan.
    Kamura S
    PDA J Pharm Sci Technol; 1994; 48(4):182-3. PubMed ID: 7804816
    [No Abstract]   [Full Text] [Related]  

  • 9. The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.
    Cinnamond M; Woods T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):133-136. PubMed ID: 26041869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 15. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accession to the PIC/S and pharmaceutical quality system in Japan].
    Katori N
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licensing under the Medicines Act and its effect on pharmacy.
    Fishburn AG
    R Soc Health J; 1974 Dec; 94(6):271-3, 95. PubMed ID: 4460083
    [No Abstract]   [Full Text] [Related]  

  • 19. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.